Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported

Go back to Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported
HAEMONETICS CORPORATION (NYSE: HAE) Delayed: 108.40 +0.80 (0.74%)
Previous Close $107.60    52 Week High $39.41 
Open $108.95    52 Week Low $25.98 
Day High $110.45    P/E 152.68 
Day Low $107.60    EPS $0.71 
Volume 1,300,442